Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Dermapharm

Explore full profile

Offers dermatological, skin care, and allergy medicines

Grünwald, GermanyFounded 1991Biotech & Life Sciences
Valuation $3.20B Market cap · Aug/2026
Revenue $1.33B Latest reported FY
EBITDA $376M Latest reported FY

At a glance

Status
Listed
Founded
1991
Headquarters
Grünwald, Germany
Listing
IPO 2018
Sector
Biotech & Life Sciences
Power Law
Unicorn$1–10B valuation tierThoroughbred$100M+ revenue

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Talent

Book a demo to see the people
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇩🇪 Germany85.2%
🇨🇭 Switzerland13.1%
🇨🇳 China1.7%
3 countries shown

Patents

Estimated portfolio value
$20M

21 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Investments and acquisitions

Disclosed deals where Dermapharm was the backer or acquirer, 2019–2023. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

6 deals across Dermapharm's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        Dermapharm's portfolio, mapped.

        Stage
        Period
        6 of 6 deals

        Market sentiment

        Posts on X, past 7 days

        An AI-synthesised read of the highest-engagement posts about Dermapharm on X, ranked by likes and reposts, corporate channels excluded.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Dermapharm on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

        Book a demo Explore company profiles